Page last updated: 2024-10-25

deferoxamine and Radiodermatitis

deferoxamine has been researched along with Radiodermatitis in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Radiodermatitis: A cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shen, AH1
Borrelli, MR1
Adem, S1
Deleon, NMD1
Patel, RA1
Mascharak, S1
Yen, SJ1
Sun, BY1
Taylor, WL1
Januszyk, M1
Nguyen, DH1
Momeni, A1
Gurtner, GC1
Longaker, MT1
Wan, DC1

Other Studies

1 other study available for deferoxamine and Radiodermatitis

ArticleYear
Prophylactic treatment with transdermal deferoxamine mitigates radiation-induced skin fibrosis.
    Scientific reports, 2020, 07-23, Volume: 10, Issue:1

    Topics: Animals; Deferoxamine; Dermis; Female; Mice; Mice, Nude; Radiation Injuries, Experimental; Radioderm

2020